Search results
5 hours ago · New England Science & Sailing, a Stonington-based ocean adventure education organization, announced that Eric Isselhardt will be stepping down from his position as Chief Executive Officer to p...
1 day ago · Kutztown University spring 2024 dean’s list. Tweet. Published June 20. 2024 08:20PM. Several local students have achieved the dean’s list at Kutztown University. To be eligible for the dean’s list, an undergraduate student must be registered for at least 12 credits and have a minimum grade-point average of 3.6. Albrightsville:
5 hours ago · Lecturing at the same International Congress session was Prof Allan Young, who provided these “FACTS” [ as shared on#RCPSYCHIC22 ]: Professor Young provided these declarations of competing interests to the Royal College of Psychiatrists. It is an extensive list: Back to that idiom: True science is disinterested. No tail needs wagged.
5 hours ago · Maria Nadotti. 21 Giugno 2024. C’è, nella lingua inglese, un modo di dire magnificamente visivo e vagamente coloniale: “An elephant in the room”. Serve a indicare una verità talmente macroscopica e indigesta che tutti preferiscono far finta di niente o minimizzarla. L’idea di base è che un elefante in salotto, in camera da letto o in ...
5 hours ago · 作者：Samuel Stevens, Jiaman Wu, Matthew J. Thompson, Elizabeth G. Campolongo, Chan Hee Song, David Edward Carlyn, Li Dong, Wasila M. Dahdul, Charles Stewart, Tanya Berger-Wolf, Wei-Lun Chao, and Yu Su. 机构：俄亥俄州立大学，微软研究院，加利福尼亚大学尔湾分校，伦斯勒理工学院
5 hours ago · 906: LIVE From the 2024 Career Education Convention - with Elizabeth Herron, VP Sales & Solutions and Andrew Benson, VP Operations - CARS; 905: LIVE From the 2024 Career Education Convention - with Josh Swayne, CEO Charter Colleges and Gary Thorup, VP Operations, MDT Marketing
5 hours ago · ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran Seven oral presentations across the hemophilia portfolio reinforce Sanofi’s commitment to bring potential first- and best-in-class treatments to the rare blood disorders communityInterim results from the long-term XTEND-ed phase 3 study demonstrate once-weekly ALTUVIIIO continues to provide highly ...
